Figure 1From: Simultaneous clinical resolution of focal segmental glomerulosclerosis associated with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab Laboratory values and white blood cell count before and after treatment with fludarabine, cyclophosphamide, and rituximab (FCR).Back to article page